Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ ... today announced the resignation of Chief Executive Officer (CEO) Mark Iwicki, and the appointment of Todd Bazemore, KALA’s President ...

Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ ... today announced the resignation of Chief Executive Officer (CEO) Mark Iwicki, and the appointment of Todd Bazemore, KALA's President ...

Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical ... today announced the resignation of Chief Executive Officer (CEO) Mark Iwicki, and the appointment ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

N.C.--(BUSINESS WIRE)--Kincell Bio, a leader in cell therapy development and manufacturing, is excited to announce the appointment of Mark R. Bamforth as Chief Executive Officer (CEO), effective ...

Feb. 04, 2025 (GLOBE NEWSWIRE) -- Uvax Bio, LLC ... today announced the appointment of Chief Business Officer Kevin O’Neill to Interim Chief Executive Officer (CEO). Mr. O’Neill succeeds ...

Many organizations are now moving from a digital-first to an AI-first philosophy. Does healthcare need a Chief AI Officer?

Feb. 04, 2025 (GLOBE NEWSWIRE) -- Uvax Bio, LLC, ("Uvax” or "the Company ... today announced the appointment of Chief Business Officer Kevin O'Neill to Interim Chief Executive Officer (CEO). Mr.

Kincell Bio, a leader in cell therapy development and manufacturing, is excited to announce the appointment of Mark R. Bamforth as Chief Executive Officer (CEO), effective immediately. Mark ...

Woodhouse, Ph.D., Chief Executive Officer at NGM Bio. “As an experienced drug developer and a skilled clinician, Wendy has a profound passion to address unmet patient needs through the ...

Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Amy E. Herr, Ph.D. to serve as an independent director on the Company's Board of Directors beginning on February 1, 2025. Dr.